Cited by 110Alzheimer's disease research and treatmentsDementia and Cognitive Impairment ResearchPrion Diseases and Protein Misfolding

Zinc Lowers Amyloid-β Toxicity by Selectively Precipitating Aggregation Intermediates

Garai, K., Sahoo, B., Kaushalya, S. K., Desai, R., Maiti, S.·2007·Biochemistry

Abstract

Soluble amyloid-beta (Abeta) aggregates are suspected to play a major role in Alzheimer's disease. Zn2+ at a concentration of a few micromolar, which is too dilute to affect the precipitation equilibrium of Abeta, can destabilize these aggregates [Garai, K., Sengupta, P., Sahoo, B., and Maiti, S. (2006) Biochem. Biophys. Res. Commun. 345, 210-215]. Here we investigate the nature of these aggregates in the context of the precipitation pathway, the mechanism underlying their destabilization, and the biological consequences of this destabilization. We show that the larger soluble aggregates (size >10 nm) form only in supersaturated Abeta solutions, implying that they are intermediates in the pathway toward fibril formation. We also show that Zn2+ destabilizes these intermediates by accelerating their aggregation kinetics. The resulting change in the size distribution of the Abeta solution is sufficient to eliminate its toxicity to cultured mammalian neurons. Our results provide an explanation for the existing observations that Zn2+ at a concentration of a few micromolar significantly reduces Abeta toxicity.

Integrity signals

Registry

Crossref · 10.1021/bi700798b

Cites

3 of 3 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • Zn2+ promotes formation of nonfibrillar aggregates.

    “Several studies showed that Zn2+ promotes formation of nonfibrillar aggregates,16,29–31 yet conflicting results have been reported for the Cu2+-mediated Aβ aggregation.”
  • Both Cu2+ and Zn2+ ions lead to a reduced ThT fluorescence, due to emission quenching by the paramagnetic Cu2+ ions or Zn2+-induced formation of non-fibrillar Aβ aggregates.

    “In addition, both Cu2+ and Zn2+ ions lead to a reduced ThT fluorescence, due to emission quenching by the paramagnetic Cu2+ ions or Zn2+-induced formation of non-fibrillar Aβ aggregetes.41,88”
  • Aggregation of Aβ42 in presence of Zn2+ leads to a small amount of amorphous aggregates, and native gel/Western blot analysis shows formation of soluble Aβ42 oligomers of various sizes.

    “By comparison, the aggregation of Aβ42 in presence of Zn2+ leads to a small amount of amorphous aggregates (Figure 8, panel c), and native gel/Western blot analysis shows formation of soluble Aβ42 oligomers of various sizes (Figure 9, lane c).88”

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Authors
Garai, K., Sahoo, B., Kaushalya, S. K., Desai, R., & Maiti, S.
Affiliations
Tata Institute of Fundamental Research (IN)
Corresponding author
Maiti, S.
Venue
Biochemistry
Published
2007-08-25
Volume
46
Issue
37
Pages
10655-10663
ISSN
  • 0006-2960 (ISSN-L)
  • 1520-4995
OpenAlex
W2083652733
Cited by
110
References
3
Citations by year
2026: 1 · 2025: 1 · 2024: 3 · 2023: 6 · 2022: 4 · 2021: 5 · 2020: 3 · 2019: 5 · 2018: 8 · 2017: 4 · 2016: 9 · 2015: 9 · 2014: 6 · 2013: 8 · 2012: 8
FWCI
3.99
Type
journal article
Language
en
Open access
closed
Locations
  • Biochemistry (publishedVersion)
  • PubMed (publishedVersion)
Funders
Advanced Centre for Treatment, Research and Education in Cancer
Topics
  • Health Sciences › Medicine › Physiology › Alzheimer's disease research and treatments
  • Health Sciences › Medicine › Psychiatry and Mental health › Dementia and Cognitive Impairment Research
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Prion Diseases and Protein Misfolding
Keywords
amyloid-beta, zinc, aggregation kinetics, fibril formation, precipitation equilibrium, supersaturation, neurotoxicity, Alzheimer's disease, zinc chelation, aggregate size distribution
MeSH terms
Animals, Neurons, Chemical Precipitation, Solubility, Zinc, Amyloid beta-Peptides, Rats, Wistar, Protein Structure, Quaternary, Rats

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review